DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Lin, Xiangmin ^a,b   Cook, Travis J ^c   Zabetian, Cyrus P ^a,d   Leverenz, James B ^a,d   Peskind, Elaine R ^a,d   Hu, Shu Ching ^a   Cain, Kevin C ^c   Pan, Catherine ^a   Edgar, John Scott ^c   Goodlett, David R ^c   Racette, Brad A ^e   Checkoway, Harvey ^c   Montine, Thomas J ^a   Shi, Min ^a   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b School of Life Sciences   (China)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ISOPROTEIN; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; SIGNAL PEPTIDE;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PROTEIN PROCESSING; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PARKINSON DISEASE; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84871820127     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00954     Document Type: Article

References (42)

1. Lang, A. E.&Lozano, A. M. Parkinson's disease. Second of two parts.NEngl J Med 339, 1130-1143 (1998). (Pubitemid 28465762)
2. Wright Willis, A., Evanoff, B. A., Lian, M., Criswell, S. R. & Racette, B. A. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology 34, 143-151 (2010).
3. Jankovic, J. Parkinson's disease: clinical features and diagnosis. JNeurolNeurosurg Psychiatry 79, 368-376 (2008). (Pubitemid 351441488)
4. Tolosa, E., Wenning, G. & Poewe, W. The diagnosis of Parkinson's disease. Lancet Neurol 5, 75-86 (2006). (Pubitemid 41790698)
5. Hong, Z. et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 133, 713-726 (2010).
6. Bonifati, V. et al. DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24, 159-160 (2003). (Pubitemid 37304291)
7. Taira, T. et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5, 213-218 (2004). (Pubitemid 38401204)
8. Diamandis, E. P., Yousef, G. M., Petraki, C. & Soosaipillai, A. R. Human kallikrein 6 as a biomarker of Alzheimer's disease. Clin Biochem 33, 663-667 (2000). (Pubitemid 32146202)
9. Bogdanov, M. et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131, 389-396 (2008). (Pubitemid 351197614)
10. Shehadeh, L. A. et al. SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. PLoS One 5, e9104 (2010).
11. Stern, E. et al. Label-free biomarker detection from whole blood. Nat Nanotechnol 5, 138-142 (2010).
12. Shi, M. et al. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett 480, 78-82 (2010).
13. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984). (Pubitemid 14076461)
14. Gibb, W. R. & Lees, A. J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51, 745-752 (1988).
15. Montine, K. S. et al. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol 57, 415-425 (1998). (Pubitemid 28237325)
16. Kawashima, Y. et al. High-yield peptide-extraction method for the discovery of subnanomolar biomarkers from small serum samples. J Proteome Res 9, 1694-1705 (2010).
17. Shi, M. et al.Mortalin: a protein associated with progression of Parkinson disease? J Neuropathol Exp Neurol 67, 117-124 (2008).
18. Jin, J. et al. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res Mol Brain Res 134, 119-138 (2005). (Pubitemid 40403644)
19. Devic, I. et al. Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain 134, e178 (2011).
20. Gygi, S. P., Corthals, G. L., Zhang, Y., Rochon, Y. & Aebersold, R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 97, 9390-9395 (2000). (Pubitemid 30650785)
21. Waragai, M. et al. a-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson's Disease. Int J Mol Sci 11, 4257-4266 (2010).
22. Waragai, M. et al. Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease. Neurosci Lett 425, 18-22 (2007). (Pubitemid 47410359)
23. Maita, C. et al. Secretion of DJ-1 into the serum of patients with Parkinson's disease. Neurosci Lett 431, 86-89 (2008).
24. Wang, J., Hoekstra, J. G., Zuo, C., Cook, T. J. & Zhang, J. Biomarkers of Parkinson's disease: current status and future perspectives. Drug Discovery Today (2012), in press: http://dx.doi.org/10.1016/j.drudis.2012.09.001
25. Rush, J. et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23, 94-101 (2005). (Pubitemid 41724631)
26. Choi, J. et al. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 281, 10816-10824 (2006). (Pubitemid 43855504)
27. Saito, Y. et al. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients. Neurosci Lett 465, 1-5 (2009).
28. Kinumi, T., Kimata, J., Taira, T., Ariga, H. & Niki, E. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun 317, 722-728 (2004). (Pubitemid 38481432)
29. Canet-Avilés, R. M. et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 101, 9103-9108 (2004). (Pubitemid 38781618)
30. Hao, L. Y., Giasson, B. I. & Bonini, N. M. DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc Natl Acad Sci USA 107, 9747-9752 (2010).
31. Tsuboi, Y. et al. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains. FEBS Lett 582, 2643-2649 (2008).
32. Akazawa, Y. O. et al. Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals. Neurosci Lett 483, 201-205 (2010).
33. Yoritaka, A. et al. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 93, 2696-2701 (1996). (Pubitemid 26114311)
34. Selley, M. L. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med 25, 169-174 (1998). (Pubitemid 28293150)
35. Ishimura, A. et al. Comparative study of hydrogen peroxide- and 4-hydroxy-2- nonenal-induced cell death in HT22 cells. Neurochem Int 52, 776-785 (2008).
36. Natale, M. et al.Ameta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1. Bioinformatics 26, 946-952 (2010).
37. Baglo, Y. et al. Photodynamic therapy with hexyl aminolevulinate induces carbonylation, posttranslational modifications and changed expression of proteins in cell survival and cell death pathways. Photochem Photobiol Sci 10, 1137-1145 (2011).
38. Duan, X., Kelsen, S. G. & Merali, S. Proteomic analysis of oxidative stressresponsive proteins in human pneumocytes: insight into the regulation of DJ-1 expression. J Proteome Res 7, 4955-4961 (2008).
39. Ferrington, D. A. & Kapphahn, R. J. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett 578, 217-223 (2004). (Pubitemid 39601784)
40. Garcia, A. et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 103, 2088-2095 (2004). (Pubitemid 38326224)
41. Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W. & Ferrington, D. A. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest Ophthalmol Vis Sci 48, 3469-3479 (2007). (Pubitemid 351261080)
42. Alberio, T. et al. Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment. IUBMB Life 62, 688-692 (2010).